Gelernter, Joel

Department of Genetics, Yale University School of Medicine, West Haven, CT, USA

Title	Year	PMID
Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality.	2021	33431810
Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction.	2021	34446935
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.	2021	32064741
A large-scale genome-wide association study meta-analysis of cannabis use disorder.	2020	33096046
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.	2020	32492095
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits.	2020	32451486
Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium.	2020	32099098
A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans.	2019	31740666
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.	2019	30478444
Evidence of causal effect of major depression on alcohol dependence: findings from the psychiatric genomics consortium.	2019	30929657
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations.	2019	30940813
Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk Loci.	2019	31151762
Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans.	2019	31358989
International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.	2019	31594949
Multivariate Analyses Reveal Biological Components Related to Neuronal Signaling and Immunity Mediating Electroencephalograms Abnormalities in Alcohol-Dependent Individuals from the Collaborative Study on the Genetics of Alcoholism Cohort.	2019	31009096
ADH1B: From alcoholism, natural selection, and cancer to the human phenome.	2018	28349588
AUDIT-C and ICD codes as phenotypes for harmful alcohol use: association with ADH1B polymorphisms in two US populations.	2018	29972609
Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans.	2018	29478698
Genomewide Association Study of Alcohol Dependence and Related Traits in a Thai Population.	2018	29460428
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.	2018	30150663

Resolved affiliation

Department of Genetics, Yale University School of Medicine, West Haven, CT, USA

Raw imported affiliations (114)

Affiliation
Department of Psychiatry, Yale University School of Medicine, VA CT 116A2, 950 Campbell Avenue, West Haven, CT 06516, USA.
Department of Psychiatry, Yale University School of Medicine, VA Psychiatry 116A2, 950 Campbell Avenue, West Haven, CT 06516, USA. joel.gelernter@yale.edu
Department of Psychiatry, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA. joel.gelernter@yale.edu.
Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA.
Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA. joel.gelernter@yale.edu.
Departments of Genetics and Neuroscience , Yale University School of Medicine, New Haven, Connecticut.
Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, CT, 06510, USA.
Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, CT, United States.
Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, CT, USA.
Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, CT, USA. joel.gelernter@yale.edu.
Departments of Psychiatry, Genetics and Neuroscience, Yale School of Medicine, New Haven, CT 06511, USA.
Departments of Psychiatry, Genetics and Neuroscience, Yale School of Medicine, New Haven, CT, 06511, USA.
Departments of Psychiatry, Genetics, and Neuroscience, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, USA. joel.gelernter@yale.edu.
Division of Human Genetics, Department of Psychiatry, VA CT Healthcare Center, Yale University School of Medicine, New Haven, CT, USA. joel.gelernter@yale.edu.
Division of Human Genetics, Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Genetics, and Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, and VA CT Healthcare Center, New Haven, CT 06516, USA.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. joel.gelernter@yale.edu.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Massachusetts; Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, Massachusetts; VA Connecticut Healthcare Center, West Haven, Massachusetts. Electronic address: joel.gelernter@yale.edu.